[go: up one dir, main page]

AU2002237733A1 - Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) - Google Patents

Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)

Info

Publication number
AU2002237733A1
AU2002237733A1 AU2002237733A AU3773302A AU2002237733A1 AU 2002237733 A1 AU2002237733 A1 AU 2002237733A1 AU 2002237733 A AU2002237733 A AU 2002237733A AU 3773302 A AU3773302 A AU 3773302A AU 2002237733 A1 AU2002237733 A1 AU 2002237733A1
Authority
AU
Australia
Prior art keywords
calsarcins
calcineurin
methods
binding proteins
muscle specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002237733A
Inventor
Norbert Frey
Eric N. Olson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of AU2002237733A1 publication Critical patent/AU2002237733A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4728—Calcium binding proteins, e.g. calmodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002237733A 2000-11-07 2001-11-07 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) Abandoned AU2002237733A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24662900P 2000-11-07 2000-11-07
US60/246,629 2000-11-07
PCT/US2001/049861 WO2002046419A2 (en) 2000-11-07 2001-11-07 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)

Publications (1)

Publication Number Publication Date
AU2002237733A1 true AU2002237733A1 (en) 2002-06-18

Family

ID=22931490

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002237733A Abandoned AU2002237733A1 (en) 2000-11-07 2001-11-07 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)

Country Status (6)

Country Link
US (4) US20030078376A1 (en)
EP (1) EP1364019A2 (en)
JP (1) JP2004528822A (en)
AU (1) AU2002237733A1 (en)
CA (1) CA2425396A1 (en)
WO (1) WO2002046419A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951411A0 (en) * 2002-09-16 2002-09-26 The University Of Sydney Genotype screen
US8227621B2 (en) 2005-06-30 2012-07-24 Li-Cor, Inc. Cyanine dyes and methods of use
US20190247415A1 (en) * 2016-07-14 2019-08-15 Mayo Foundation For Medical Education And Research Methods and materials for activating muscle remodeling
EA202090688A1 (en) 2017-09-13 2020-07-06 Эмджен Инк. BIS-AMIDE CONNECTIONS ACTIVATING SARCOMER AND VARIANTS OF THEIR APPLICATION

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5723436A (en) * 1994-10-24 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Calcineurin interacting protein compositions and methods
US6201165B1 (en) * 1997-10-16 2001-03-13 Board Of Regents, University Of Texas System Transgenic animal models for cardiac hypertrophy and methods of use thereof
WO2001053312A1 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
CA2410949A1 (en) * 2000-05-30 2001-12-06 Medigene Ag Novel target genes for diseases of the heart
US20020197679A1 (en) * 2000-06-20 2002-12-26 Tang Y. Tom Novel nucleic acids and polypeptides
US7629308B2 (en) * 2000-07-07 2009-12-08 Board Of Regents, The University Of Texas System Methods relating to muscle selective calcineurin interacting protein (MCIP)

Also Published As

Publication number Publication date
WO2002046419A2 (en) 2002-06-13
US20040210950A1 (en) 2004-10-21
US20040186275A1 (en) 2004-09-23
JP2004528822A (en) 2004-09-24
CA2425396A1 (en) 2002-06-13
EP1364019A2 (en) 2003-11-26
US20040127686A1 (en) 2004-07-01
US20030078376A1 (en) 2003-04-24
WO2002046419A3 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
AU2002237124B2 (en) Compositions and methods relating to osteoarthritis
AU2001276048A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001279284A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001292842A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2002249787A1 (en) Compositions and methods relating to lung specific genes and proteins
AU2002220009A1 (en) Compositions and methods relating to lung specific genes and proteins
AU3837201A (en) Low tack cosmetic composition sticks
AU2002345878A1 (en) Ilt3 and ilt4-related compositions and methods
AU2001297741A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
AU2002237733A1 (en) Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
AU2002360531A1 (en) Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201
AU2001273305A1 (en) Methods and compositions relating to muscle selective calcineurin interacting protein (mcip)
AU2001297575A1 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
AU2002217991A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2001277937A1 (en) Compositions and methods relating to lung specific genes
AU2002241730A1 (en) Compositions and methods relating to lung specific genes and proteins
AU2002236534A1 (en) Compositions and methods relating to ovary specific genes and proteins
AU2002253946A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2002331780A1 (en) Compositions and methods relating to lung specific genes and proteins
AU2001297794A1 (en) Methods and compositions of human proteins and uses thereof.
AU2002230736A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2002360343A1 (en) Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587, 10183, 10550, 12680, 17921, 32248, 60489 or 93804
AUPQ876400A0 (en) Compositions and method of using them
AU2001290586A1 (en) Compositions and methods relating to hypertension